Cargando…

Reply to Čulić et al—COVID-19 Pandemic and Possible Rebound Phenomenon in Incidence of Acute Myocardial Infarction

Detalles Bibliográficos
Autores principales:	Fardman, Alexander, Oren, Daniel, Beigel, Roy, Matetzky, Shlomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Canadian Cardiovascular Society. Published by Elsevier Inc. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427769/ https://www.ncbi.nlm.nih.gov/pubmed/33326813 http://dx.doi.org/10.1016/j.cjca.2020.12.007

Ejemplares similares

Post COVID-19 Acute Myocardial Infarction Rebound
por: Fardman, Alexander, et al.
Publicado: (2020)

COVID-19 Pandemic and Possible Rebound Phenomenon in Incidence of Acute Myocardial Infarction
por: Čulić, Viktor, et al.
Publicado: (2021)

Pericardial Involvement in ST-Segment Elevation Myocardial Infarction as Detected by Cardiac MRI
por: Massalha, Eias, et al.
Publicado: (2022)

Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging
por: Massalha, Eias, et al.
Publicado: (2022)

Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis
por: Regev, Ehud, et al.
Publicado: (2018)

Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes—A multicenter registry
por: Fardman, Alexander, et al.
Publicado: (2021)

Letter to the Editor: Acute Coronary Syndrome Trends and COVID-19 Waves (Response to the Letter of Čulić et al.)
por: Sutherland, Nigel, et al.
Publicado: (2022)

Feasibility and Safety of Evaluating Patients with Prior Coronary Artery Disease Using an Accelerated Diagnostic Algorithm in a Chest Pain Unit
por: Beigel, Roy, et al.
Publicado: (2016)

The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients
por: Mazin, Israel, et al.
Publicado: (2022)

Reply to Gayet et al.: Minority salience as a social and cognitive phenomenon
por: Kardosh, Rasha, et al.
Publicado: (2022)

Immediate and early percutaneous coronary intervention in very high‐risk and high‐risk non‐ST segment elevation myocardial infarction patients
por: Lupu, Lior, et al.
Publicado: (2022)

Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
por: Anastasilakis, Athanasios D., et al.
Publicado: (2021)

Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
por: Kim, Albert S., et al.
Publicado: (2022)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
por: Anık, Ahmet
Publicado: (2022)

The burden of heart failure in cardiac intensive care unit: a prospective 7 years analysis
por: Grupper, Avishay, et al.
Publicado: (2023)

Type-II Myocardial Infarction – Patient Characteristics, Management and Outcomes
por: Stein, Gideon Y., et al.
Publicado: (2014)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Reply to Chase et al. and to Milner et al.
por: Mittel, Aaron M., et al.
Publicado: (2020)

Reply by Xu et al. to Haouzi et al.
por: Xu, Yonghao, et al.
Publicado: (2020)

Reply by Pan et al. to Haouzi et al.
por: Pan, Chun, et al.
Publicado: (2020)

Reply to Topeli et al. and to Akinosoglou et al.
por: Azevedo, Luciano C. P., et al.
Publicado: (2020)

Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020)

Reply to Shoemark et al. and to Shapiro et al.
por: Amirav, Israel, et al.
Publicado: (2020)

Reply to Gueret et al. and to Hammond et al.
por: Brown, Ryan M., et al.
Publicado: (2020)

Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021)

Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Reply to Nie et al. and Bhammar et al.
por: Peters, Michael C., et al.
Publicado: (2022)

Reply to Fillatre et al. and Li et al.
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2022)

A Postoperative Phenomenon of Percutaneous Endoscopic Lumbar Discectomy: Rebound Pain
por: Zhang, Chang, et al.
Publicado: (2021)

Reply to Olschewski et al.: TMEM16A Potentiation: Possible Drawbacks
por: Danahay, Henry L., et al.
Publicado: (2020)

Reply to Qiu et al.: Hunting for leadership “causal” genes: Mission possible?
por: Song, Zhaoli, et al.
Publicado: (2022)

THARYAN ET AL REPLY
por: Tharyan, Prathap, et al.
Publicado: (1994)

THARYAN ET AL'S REPLY
por: Tharyan, Prathap
Publicado: (1995)

Gabrielse et al. Reply:
por: Gabrielse, G, et al.
Publicado: (2004)

Gabrielse et al. Reply
por: Gabrielse, G, et al.
Publicado: (2004)

Reply to Pawar et al
por: Todd, Stacy, et al.
Publicado: (2014)

Reply to Farmakiotis et al
por: Waddington, Claire S., et al.
Publicado: (2014)

Reply to Cunnington et al
por: Hanson, Josh, et al.
Publicado: (2013)

Reply to Yates et al
por: Middelkoop, Keren, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qopnqffte1f3v3llivnihr290o